To: All persons and/or entities who purchased common stock in KaloBios Pharmaceuticals, Inc. [NASDAQ: KBIO] during the period from November 18, 2015 to December 16, 2015, and were damaged thereby; a settlement has been announced in the securities litigation known as In re KaloBios Pharmaceuticals, Inc. Securities Litigation, Case No. 5:15-cv-05841, United States District Court for the Northern District of California.. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is April 6, 2017.  The […]